Picardi A, Pasquini P, Cattaruzza MS, Gaetano P, Melchi CF, Baliva G, Camaioni D, Tiago A, Abeni D, Biondi M (2003). „Stressful life events, social support, attachment security and alexithymia in vitiligo. A case-control study”. Psychotherapy and Psychosomatics72 (3): 150–8. DOI:10.1159/000069731. PMID12707482.
Scherschun, L; Kim, JJ; Lim, HW (2001). „Narrow-band ultraviolet B is a useful and well-tolerated treatment for vitiligo”. Journal of the American Academy of Dermatology44 (6): 999–1003. DOI:10.1067/mjd.2001.114752. PMID11369913.
Silverberg NB, Lin P, Travis L, et al. (November 2004). „Tacrolimus ointment promotes repigmentation of vitiligo in children: a review of 57 cases”. Journal of the American Academy of Dermatology51 (5): 760–6. DOI:10.1016/j.jaad.2004.05.036. PMID15523355.
Kwinter J, Pelletier J, Khambalia A, Pope E (February 2007). „High-potency steroid use in children with vitiligo: a retrospective study”. Journal of the American Academy of Dermatology56 (2): 236–41. DOI:10.1016/j.jaad.2006.08.017. PMID17224367.
Strömberg S, Björklund MG, Asplund A, et al. (April 2008). „Transcriptional profiling of melanocytes from patients with vitiligo vulgaris”. Pigment Cell & Melanoma Research21 (2): 162–71. DOI:10.1111/j.1755-148X.2007.00429.x. PMID18426409.
Hedstrand H, Ekwall O, Olsson MJ, et al. (September 2001). „The transcription factors SOX9 and SOX10 are vitiligo autoantigens in autoimmune polyendocrine syndrome type I”. The Journal of Biological Chemistry276 (38): 35390–5. DOI:10.1074/jbc.M102391200. PMID11423552.
Gregersen PK (March 2007). „Modern genetics, ancient defenses, and potential therapies”. The New England Journal of Medicine356 (12): 1263–6. DOI:10.1056/NEJMe078017. PMID17377166.
Jin Y, Mailloux CM, Gowan K, et al. (March 2007). „NALP1 in vitiligo-associated multiple autoimmune disease”. The New England Journal of Medicine356 (12): 1216–25. DOI:10.1056/NEJMoa061592. PMID17377159.
„FOX TV Reporter Refuses to Give In to Skin Disorder Turning Him White”. Associated Press. Fox News Channel. 2007-12-17. Pristupljeno 2009-02-09. »'I'm a black man turning white on television and people can see it,' says Thomas, an anchor and entertainment reporter for the local Fox Broadcasting Company affiliate. 'If you've watched me over the years, you've seen my hands completely change from brown to white.'«
guardian.co.uk
observer.guardian.co.uk
Barber, Lynn (2001-10-28). „Glad to be Graham”. The Guardian (London). Pristupljeno 2010-04-09.
Huggins RH, Schwartz RA, Janniger CK (December 2005). „Vitiligo”. Acta Dermatovenerologica Alpina, Panonica, et Adriatica14 (4): 137–42, 144–5. PMID16435042.
Picardi A, Pasquini P, Cattaruzza MS, Gaetano P, Melchi CF, Baliva G, Camaioni D, Tiago A, Abeni D, Biondi M (2003). „Stressful life events, social support, attachment security and alexithymia in vitiligo. A case-control study”. Psychotherapy and Psychosomatics72 (3): 150–8. DOI:10.1159/000069731. PMID12707482.
Scherschun, L; Kim, JJ; Lim, HW (2001). „Narrow-band ultraviolet B is a useful and well-tolerated treatment for vitiligo”. Journal of the American Academy of Dermatology44 (6): 999–1003. DOI:10.1067/mjd.2001.114752. PMID11369913.
Tanghetti EA (February 2003). „Tacrolimus ointment 0.1% produces repigmentation in patients with vitiligo: results of a prospective patient series”. Cutis71 (2): 158–62. PMID12635898.
Silverberg NB, Lin P, Travis L, et al. (November 2004). „Tacrolimus ointment promotes repigmentation of vitiligo in children: a review of 57 cases”. Journal of the American Academy of Dermatology51 (5): 760–6. DOI:10.1016/j.jaad.2004.05.036. PMID15523355.
Juhlin L, Olsson MJ (November 1997). „Improvement of vitiligo after oral treatment with vitamin B12 and folic acid and the importance of sun exposure”. Acta Derm. Venereol.77 (6): 460–2. PMID9394983.
Kwinter J, Pelletier J, Khambalia A, Pope E (February 2007). „High-potency steroid use in children with vitiligo: a retrospective study”. Journal of the American Academy of Dermatology56 (2): 236–41. DOI:10.1016/j.jaad.2006.08.017. PMID17224367.
Strömberg S, Björklund MG, Asplund A, et al. (April 2008). „Transcriptional profiling of melanocytes from patients with vitiligo vulgaris”. Pigment Cell & Melanoma Research21 (2): 162–71. DOI:10.1111/j.1755-148X.2007.00429.x. PMID18426409.
Hedstrand H, Ekwall O, Olsson MJ, et al. (September 2001). „The transcription factors SOX9 and SOX10 are vitiligo autoantigens in autoimmune polyendocrine syndrome type I”. The Journal of Biological Chemistry276 (38): 35390–5. DOI:10.1074/jbc.M102391200. PMID11423552.
Gregersen PK (March 2007). „Modern genetics, ancient defenses, and potential therapies”. The New England Journal of Medicine356 (12): 1263–6. DOI:10.1056/NEJMe078017. PMID17377166.
Jin Y, Mailloux CM, Gowan K, et al. (March 2007). „NALP1 in vitiligo-associated multiple autoimmune disease”. The New England Journal of Medicine356 (12): 1216–25. DOI:10.1056/NEJMoa061592. PMID17377159.
„Turning White”. Turning White. Arhivirano iz originala na datum 2010-08-19. Pristupljeno 2011-01-31.
wiley.com
onlinelibrary.wiley.com
Mashaghi A et al. Possible association of the CD4 gene polymorphism with vitiligo. Clin Exp Dermatol. (2010) 35(5):521-4. link
worldcat.org
Halder RM, et al. (2007). „72. Vitiligo”. u: Wolff K, Freedberg IM, Fitzpatrick TB (eds). Fitzpatrick's dermatology in general medicine (7th izd.). New York: McGraw-Hill Professional. ISBN978-0-07-146690-5. OCLC154751587.
Epstein, Angela; Fielding, Yvette (6 May 2003). „My skin colour changed from dark olive to a bleach white”. Daily Mail (London: Associated Newspapers): str. 39. ISSN0307-7578.